Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ryan

Showing results (551-560 of 4,371) with videos related to

Pageof 438
Sort By:
Frontiers in Aging Neuroscience|December 5, 2022
Deep learning approaches for noncoding variant prioritization in neurodegenerative diseasesAlexander Y Lan, M Ryan Corces
Journal of Cell Science|May 30, 2012
Autophagy and cancer--issues we need to digestEmma Y Liu, Kevin M Ryan
Acta Psychiatrica Scandinavica|October 9, 2018
From molecules to mind: mechanisms of action of electroconvulsive therapyK M Ryan, D M McLoughlin
Focus (American Psychiatric Publishing)|February 5, 2020
From Molecules to Mind: Mechanisms of Action of Electroconvulsive TherapyK M Ryan, D M McLoughlin
Seminars in Cell & Developmental Biology|June 2, 2022
The therapeutic potential of the neuroactive peptides of soluble amyloid precursor protein-alpha in Alzheimer's disease and related neurological disordersBruce G Mockett, Margaret M Ryan
Annals of Internal Medicine|May 21, 2014
The Affordable Care Act's payment reforms and the future of hospitalsAndrew M Ryan, Alvin I Mushlin
Children (Basel, Switzerland)|April 3, 2021
Genetic Testing for Neonatal Respiratory DiseaseLawrence M Nogee, Rita M Ryan
Cell Cycle (Georgetown, Tex.)|August 28, 2007
Targeting the p53 family for cancer therapy: 'big brother' joins the fightHelen S Bell, Kevin M Ryan
Cell Research|October 16, 2007
Hzf and hCAS/CSE1L: making the right choice in p53-mediated tumour suppressionKatherine E Ewings, Kevin M Ryan
Acta Physiologica Scandinavica|July 1, 1994
Effect of ouabain and verapamil on restoration of contraction by adrenaline during high K+ in the frog heartD M Ryan, D J Paterson
Pageof 438

Showing results (551-560 of 4,371) with videos related to

Sort By:
Pageof 438
Frontiers in Aging Neuroscience|December 5, 2022
Deep learning approaches for noncoding variant prioritization in neurodegenerative diseasesAlexander Y Lan, M Ryan Corces
Journal of Cell Science|May 30, 2012
Autophagy and cancer--issues we need to digestEmma Y Liu, Kevin M Ryan
Acta Psychiatrica Scandinavica|October 9, 2018
From molecules to mind: mechanisms of action of electroconvulsive therapyK M Ryan, D M McLoughlin
Focus (American Psychiatric Publishing)|February 5, 2020
From Molecules to Mind: Mechanisms of Action of Electroconvulsive TherapyK M Ryan, D M McLoughlin
Seminars in Cell & Developmental Biology|June 2, 2022
The therapeutic potential of the neuroactive peptides of soluble amyloid precursor protein-alpha in Alzheimer's disease and related neurological disordersBruce G Mockett, Margaret M Ryan
Annals of Internal Medicine|May 21, 2014
The Affordable Care Act's payment reforms and the future of hospitalsAndrew M Ryan, Alvin I Mushlin
Children (Basel, Switzerland)|April 3, 2021
Genetic Testing for Neonatal Respiratory DiseaseLawrence M Nogee, Rita M Ryan
Cell Cycle (Georgetown, Tex.)|August 28, 2007
Targeting the p53 family for cancer therapy: 'big brother' joins the fightHelen S Bell, Kevin M Ryan
Cell Research|October 16, 2007
Hzf and hCAS/CSE1L: making the right choice in p53-mediated tumour suppressionKatherine E Ewings, Kevin M Ryan
Acta Physiologica Scandinavica|July 1, 1994
Effect of ouabain and verapamil on restoration of contraction by adrenaline during high K+ in the frog heartD M Ryan, D J Paterson
Pageof 438